SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-027941
Filing Date
2023-08-08
Accepted
2023-08-08 07:16:09
Documents
63
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cccc-20230630.htm   iXBRL 10-Q 1406762
2 EX-31.1 cccc-20230630xexx311.htm EX-31.1 10369
3 EX-31.2 cccc-20230630xexx312.htm EX-31.2 10415
4 EX-32.1 cccc-20230630xexx321.htm EX-32.1 4745
5 EX-32.2 cccc-20230630xexx322.htm EX-32.2 4761
  Complete submission text file 0001628280-23-027941.txt   5855395

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cccc-20230630.xsd EX-101.SCH 41177
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cccc-20230630_cal.xml EX-101.CAL 67900
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cccc-20230630_def.xml EX-101.DEF 155976
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cccc-20230630_lab.xml EX-101.LAB 484323
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cccc-20230630_pre.xml EX-101.PRE 299392
57 EXTRACTED XBRL INSTANCE DOCUMENT cccc-20230630_htm.xml XML 760670
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39567 | Film No.: 231149306
SIC: 2836 Biological Products, (No Diagnostic Substances)